145Low toxicity and efficacy of 153-samarium-EDTMP/MELPHALAN as a conditioning regimen for secondary acute myelogenous leukemia

Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy

“…One of the patients have been reported in a prior publication. 4 Median age at the time of the transplant was 57 years (range 15-71). Three patients had been primarily diagnosed with follicular lymphoma, two with multiple myeloma and one with Ewing's sarcoma.…”